ANTACID

ANTACID was reported 48459 times

ANTACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MILK-ALKALI SYNDROME 318 0.6080
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 102 0.5698
2 VAGINAL FLATULENCE 169 0.5578
3 PULMONARY VASCULITIS 215 0.3996
4 LUPUS VULGARIS 492 0.3905
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 256 0.3832
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 764 0.3814
7 TOTAL LUNG CAPACITY INCREASED 102 0.3750
8 C-REACTIVE PROTEIN 327 0.3528
9 GRIP STRENGTH 79 0.3450
10 TOTAL LUNG CAPACITY ABNORMAL 132 0.3393
11 ANTACID THERAPY 44 0.3385
12 SWOLLEN JOINT COUNT INCREASED 1075 0.3368
13 RHEUMATIC FEVER 1435 0.3216
14 SLEEP DISORDER THERAPY 62 0.3131
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 633 0.3052
16 SWOLLEN JOINT COUNT 76 0.3040
17 FACET JOINT SYNDROME 939 0.2881
18 NEUROLOGIC NEGLECT SYNDROME 158 0.2842
19 DISLOCATION OF VERTEBRA 613 0.2685
20 SPIROMETRY ABNORMAL 149 0.2492
21 CAPILLARITIS 68 0.2464
22 X-RAY ABNORMAL 430 0.2402
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 134 0.2389
24 MITE ALLERGY 145 0.2214
25 RETINITIS 374 0.2163
26 DUODENAL ULCER PERFORATION 1571 0.2110
27 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 151 0.2060
28 RHEUMATOID FACTOR POSITIVE 1167 0.2018
29 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 103 0.1969
30 CAROTID ARTERY THROMBOSIS 161 0.1896
31 SHUNT STENOSIS 51 0.1841
32 ANALGESIC THERAPY 58 0.1807
33 SERONEGATIVE ARTHRITIS 205 0.1789
34 APPENDICOLITH 68 0.1757
35 PERIPHERAL VENOUS DISEASE 718 0.1756
36 MYCOTIC ALLERGY 149 0.1743
37 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1220 0.1701
38 HELICOBACTER INFECTION 1604 0.1559
39 HYPOCHOLESTEROLAEMIA 55 0.1558
40 DUST ALLERGY 146 0.1488
41 PEMPHIGUS 1789 0.1429
42 NEURITIS 217 0.1405
43 DRUG THERAPY 46 0.1357
44 MUSCLE INJURY 1123 0.1354
45 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 878 0.1351
46 C-REACTIVE PROTEIN ABNORMAL 865 0.1347
47 MULTIPLE DRUG THERAPY 100 0.1326
48 HAND DEFORMITY 1697 0.1293
49 FOLLICULITIS 1346 0.1282
50 ADJUSTMENT DISORDER 159 0.1223
51 BONE EROSION 405 0.1144
52 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 220 0.1078
53 FEMALE GENITAL TRACT FISTULA 180 0.1053
54 CONJUNCTIVITIS ALLERGIC 152 0.1026
55 LIP DRY 932 0.1025
56 BREAST CANCER STAGE III 636 0.0981
57 PERICARDITIS 1643 0.0977
58 JOINT RANGE OF MOTION DECREASED 1307 0.0974
59 RESPIRATORY SYMPTOM 266 0.0934
60 GRIP STRENGTH DECREASED 822 0.0933
61 SYNOVITIS 1676 0.0929
62 PORPHYRIA ACUTE 132 0.0920
63 HYPERCHOLESTEROLAEMIA 873 0.0903
64 WOUND INFECTION 910 0.0830
65 GLOSSODYNIA 1843 0.0822
66 SPUTUM PURULENT 54 0.0821
67 STEROID DEPENDENCE 71 0.0809
68 NASAL OEDEMA 145 0.0802
69 OBSTRUCTIVE SLEEP APNOEA SYNDROME 113 0.0775
70 AUTOIMMUNE DISORDER 748 0.0767
71 RADICULOPATHY 198 0.0751
72 BURSITIS 901 0.0742
73 CHRONIC SINUSITIS 276 0.0735
74 DRUG TOLERANCE DECREASED 196 0.0697
75 ONYCHOMADESIS 289 0.0688
76 RECALLED PRODUCT 119 0.0687
77 CREATININE RENAL CLEARANCE INCREASED 51 0.0682
78 MYOGLOBIN BLOOD INCREASED 104 0.0680
79 CATARRH 61 0.0675
80 LIVER INJURY 1656 0.0674
81 HYPERPHOSPHATAEMIA 142 0.0660
82 IRRITABLE BOWEL SYNDROME 1414 0.0659
83 HYPOPARATHYROIDISM 50 0.0652
84 FIBROMYALGIA 1575 0.0647
85 PROCTITIS 181 0.0646
86 WOUND 1799 0.0643
87 LIVE BIRTH 522 0.0623
88 PERSONALITY DISORDER 162 0.0618
89 NEPHROCALCINOSIS 72 0.0607
90 BLEPHAROSPASM 382 0.0606
91 SCIATICA 938 0.0588
92 SYSTEMIC LUPUS ERYTHEMATOSUS 2019 0.0568
93 EXOSTOSIS 518 0.0567
94 PULMONARY FIBROSIS 1080 0.0562
95 NORMOCHROMIC NORMOCYTIC ANAEMIA 168 0.0559
96 DEATH NEONATAL 76 0.0546
97 ONYCHOMYCOSIS 235 0.0535
98 JAUNDICE CHOLESTATIC 188 0.0532
99 CALCIPHYLAXIS 97 0.0528
100 WALKING AID USER 346 0.0524
101 OBSTRUCTIVE AIRWAYS DISORDER 583 0.0524
102 METABOLIC ALKALOSIS 84 0.0523
103 NASAL OBSTRUCTION 98 0.0522
104 SEDATION COMPLICATION 133 0.0521
105 HYPOMANIA 191 0.0519
106 FORCED EXPIRATORY VOLUME DECREASED 139 0.0490
107 PSORIATIC ARTHROPATHY 1982 0.0488
108 TYPE 2 DIABETES MELLITUS 1636 0.0485
109 OBESITY 766 0.0480
110 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 44 0.0475
111 FULL BLOOD COUNT ABNORMAL 488 0.0461
112 MATERNAL EXPOSURE TIMING UNSPECIFIED 168 0.0447
113 IMPAIRED HEALING 1462 0.0445
114 CONTRAINDICATED PRODUCT ADMINISTERED 1323 0.0437
115 LUPUS-LIKE SYNDROME 392 0.0432
116 SECONDARY IMMUNODEFICIENCY 51 0.0420
117 NAIL DISORDER 364 0.0416
118 HYPERPARATHYROIDISM SECONDARY 103 0.0411
119 ARTERIOSCLEROSIS CORONARY ARTERY 272 0.0410
120 BREAST CANCER STAGE II 341 0.0409
121 WHEEZING 2414 0.0407
122 PULMONARY ALVEOLAR HAEMORRHAGE 228 0.0406
123 PRESCRIBED OVERDOSE 780 0.0403
124 NEUROLOGICAL SYMPTOM 230 0.0402
125 BRAIN NATRIURETIC PEPTIDE INCREASED 124 0.0402
126 LOWER LIMB FRACTURE 771 0.0401
127 MACULAR DEGENERATION 479 0.0401
128 FINGER DEFORMITY 194 0.0400
129 JOINT DISLOCATION 422 0.0399
130 PUSTULAR PSORIASIS 137 0.0398
131 NONINFECTIVE GINGIVITIS 57 0.0393
132 HIP ARTHROPLASTY 598 0.0390
133 HYPERCALCAEMIA 481 0.0389
134 RED BLOOD CELL SEDIMENTATION RATE INCREASED 427 0.0386
135 NASAL POLYPS 189 0.0383
136 SPONDYLITIS 138 0.0379
137 FOOT DEFORMITY 409 0.0369
138 ULCER HAEMORRHAGE 249 0.0368
139 CREATININE RENAL CLEARANCE DECREASED 146 0.0364
140 PLANTAR FASCIITIS 121 0.0360
141 BRONCHIECTASIS 239 0.0354
142 BLOOD PHOSPHORUS INCREASED 96 0.0351
143 BURNS SECOND DEGREE 61 0.0347
144 BLOOD CHOLESTEROL INCREASED 1614 0.0346
145 ARTHROPATHY 1865 0.0335
146 HYPOCALCAEMIA 634 0.0335
147 GAIT INABILITY 1076 0.0322
148 CHRONIC FATIGUE SYNDROME 44 0.0316
149 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 535 0.0315
150 HYPERPARATHYROIDISM 64 0.0310
151 RASH VESICULAR 150 0.0310
152 PRESCRIBED UNDERDOSE 614 0.0307
153 OSTEOARTHRITIS 1304 0.0307
154 BLOOD CALCIUM DECREASED 337 0.0299
155 EYE INJURY 90 0.0296
156 INFUSION RELATED REACTION 1937 0.0292
157 TETANY 53 0.0290
158 PRODUCT LABEL CONFUSION 169 0.0290
159 TOTAL LUNG CAPACITY DECREASED 46 0.0288
160 RHINITIS ALLERGIC 128 0.0287
161 LOWER RESPIRATORY TRACT INFECTION 1301 0.0286
162 COELIAC DISEASE 276 0.0281
163 GANGRENE 168 0.0279
164 C-REACTIVE PROTEIN INCREASED 997 0.0274
165 HEPATIC ENZYME INCREASED 1847 0.0271
166 LABYRINTHITIS 68 0.0269
167 OEDEMA 1443 0.0266
168 OSTEITIS 67 0.0265
169 MOBILITY DECREASED 1902 0.0264
170 THROAT CLEARING 98 0.0261
171 KYPHOSIS 46 0.0260
172 KNEE ARTHROPLASTY 548 0.0260
173 STOMATITIS 1576 0.0260
174 CARDIAC MURMUR 224 0.0259
175 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 443 0.0258
176 BLISTER 1442 0.0257
177 HYPOPHOSPHATAEMIA 188 0.0254
178 SPINAL FUSION SURGERY 103 0.0254
179 SARCOIDOSIS 119 0.0250
180 NIGHT SWEATS 806 0.0250
181 ARTERIOSCLEROSIS 235 0.0249
182 HEPATIC CIRRHOSIS 464 0.0247
183 VASCULITIS 284 0.0244
184 BLOOD PRESSURE DIASTOLIC ABNORMAL 62 0.0244
185 DELIRIUM 833 0.0240
186 NEPHROGENIC SYSTEMIC FIBROSIS 72 0.0238
187 LOOSE TOOTH 76 0.0236
188 BLOOD PARATHYROID HORMONE INCREASED 68 0.0233
189 BACK INJURY 251 0.0231
190 MYOSITIS 207 0.0230
191 SENSORY LOSS 183 0.0227
192 LUNG DISORDER 1111 0.0226
193 TASTE DISORDER 459 0.0226
194 DISCOMFORT 1378 0.0226
195 ROAD TRAFFIC ACCIDENT 940 0.0224
196 ALCOHOL POISONING 60 0.0224
197 INJURY 1557 0.0221
198 INFUSION SITE REACTION 66 0.0221
199 SCHIZOPHRENIA 268 0.0220
200 SWELLING 2011 0.0215
201 MUSCLE SPASTICITY 264 0.0215
202 THERAPEUTIC PRODUCT EFFECT DECREASED 962 0.0215
203 INFLAMMATION 1105 0.0214
204 GENERAL SYMPTOM 160 0.0213
205 BLOOD CALCIUM INCREASED 187 0.0213
206 ARTERIAL OCCLUSIVE DISEASE 167 0.0212
207 IRON DEFICIENCY 93 0.0207
208 RHEUMATOID ARTHRITIS 2340 0.0206
209 HEMIPLEGIA 171 0.0205
210 FIBROSIS 62 0.0201
211 AORTIC STENOSIS 70 0.0201
212 NEPHROGENIC ANAEMIA 92 0.0198
213 RENAL FUNCTION TEST ABNORMAL 92 0.0198
214 SLEEP DISORDER 1386 0.0196
215 LIVER FUNCTION TEST INCREASED 419 0.0195
216 CONGENITAL ANOMALY 150 0.0194
217 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 97 0.0191
218 MOTOR DYSFUNCTION 195 0.0191
219 DYSLIPIDAEMIA 97 0.0191
220 MUSCULOSKELETAL STIFFNESS 1673 0.0191
221 JOINT STIFFNESS 496 0.0189
222 LIVER DISORDER 831 0.0187
223 HYPOPNOEA 65 0.0187
224 MUSCULOSKELETAL PAIN 977 0.0186
225 ATYPICAL FEMUR FRACTURE 52 0.0184
226 OSTEOPOROSIS 753 0.0183
227 CHEST X-RAY ABNORMAL 56 0.0182
228 BLOOD IMMUNOGLOBULIN E INCREASED 44 0.0182
229 RHINITIS 146 0.0181
230 RESPIRATORY TRACT INFECTION 471 0.0181
231 COORDINATION ABNORMAL 252 0.0180
232 GENERAL PHYSICAL HEALTH DETERIORATION 2073 0.0179
233 DRUG INTOLERANCE 1726 0.0178
234 LUNG OPACITY 47 0.0178
235 SPUTUM DISCOLOURED 168 0.0177
236 ORAL CANDIDIASIS 233 0.0177
237 NODULE 230 0.0176
238 DRUG-INDUCED LIVER INJURY 549 0.0175
239 FREQUENT BOWEL MOVEMENTS 472 0.0175
240 AFFECT LABILITY 168 0.0174
241 SINUS CONGESTION 233 0.0172
242 BREATH SOUNDS ABNORMAL 85 0.0172
243 RALES 100 0.0172
244 VAGINAL DISCHARGE 174 0.0172
245 EPILEPSY 520 0.0170
246 ILL-DEFINED DISORDER 1028 0.0169
247 EXERCISE TOLERANCE DECREASED 97 0.0168
248 JOINT SWELLING 2034 0.0168
249 SECRETION DISCHARGE 209 0.0167
250 ASTHMA 1875 0.0166
251 NORMAL NEWBORN 90 0.0165
252 SINUSITIS 1693 0.0165
253 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1161 0.0163
254 INTENTIONAL PRODUCT USE ISSUE 1416 0.0161
255 EAR PAIN 314 0.0161
256 LUNG CONSOLIDATION 45 0.0161
257 ANGIOPATHY 90 0.0160
258 GASTROOESOPHAGEAL REFLUX DISEASE 1286 0.0160
259 DRY MOUTH 1296 0.0160
260 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 767 0.0160
261 MATERNAL EXPOSURE DURING PREGNANCY 1421 0.0159
262 DIASTOLIC DYSFUNCTION 49 0.0159
263 CLOSTRIDIUM DIFFICILE COLITIS 168 0.0158
264 UPPER-AIRWAY COUGH SYNDROME 130 0.0158
265 DYSPEPSIA 1551 0.0157
266 LEFT VENTRICULAR HYPERTROPHY 67 0.0156
267 DISABILITY 305 0.0154
268 APLASIA PURE RED CELL 53 0.0154
269 STRESS FRACTURE 83 0.0154
270 BLOOD PRESSURE INADEQUATELY CONTROLLED 92 0.0153
271 HYPOMAGNESAEMIA 211 0.0151
272 EAR INFECTION 402 0.0151
273 BLOOD URIC ACID INCREASED 87 0.0151
274 PATHOLOGICAL FRACTURE 76 0.0150
275 PARAESTHESIA ORAL 216 0.0150
276 CUSHINGOID 48 0.0149
277 VENTRICULAR HYPOKINESIA 48 0.0149
278 HYPERLIPIDAEMIA 178 0.0149
279 VASCULAR DEVICE INFECTION 67 0.0148
280 CONTUSION 1416 0.0147
281 PNEUMONIA ASPIRATION 366 0.0146
282 INCREASED UPPER AIRWAY SECRETION 75 0.0146
283 LUNG NEOPLASM 62 0.0145
284 ABDOMINAL DISCOMFORT 2432 0.0145
285 SENSATION OF FOREIGN BODY 119 0.0141
286 END STAGE RENAL DISEASE 257 0.0141
287 GASTROINTESTINAL DISORDER 1254 0.0140
288 HYPOVOLAEMIA 81 0.0138
289 CHOLELITHIASIS 449 0.0137
290 RESPIRATORY TRACT CONGESTION 216 0.0136
291 ADVERSE REACTION 180 0.0136
292 AMNESIA 883 0.0136
293 CONFUSIONAL STATE 2184 0.0135
294 SINUS DISORDER 267 0.0135
295 HYPOAESTHESIA 2012 0.0134
296 BLOOD ALBUMIN DECREASED 106 0.0133
297 HEMIPARESIS 226 0.0133
298 RECTAL HAEMORRHAGE 572 0.0133
299 RENAL CYST 105 0.0132
300 BLOOD PHOSPHORUS DECREASED 48 0.0131
301 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 50 0.0131
302 EXPOSURE DURING PREGNANCY 812 0.0131
303 OEDEMA PERIPHERAL 1586 0.0130
304 ORTHOSTATIC HYPOTENSION 226 0.0130
305 BENIGN PROSTATIC HYPERPLASIA 67 0.0130
306 THERAPY NON-RESPONDER 583 0.0130
307 ATELECTASIS 125 0.0129
308 HAEMOPTYSIS 358 0.0128
309 SKIN HAEMORRHAGE 190 0.0128
310 TREATMENT FAILURE 1060 0.0128
311 BLOOD PRESSURE DIASTOLIC INCREASED 59 0.0128
312 RED CELL DISTRIBUTION WIDTH INCREASED 53 0.0127
313 BACK DISORDER 207 0.0127
314 DIVERTICULUM 90 0.0127
315 HAEMORRHAGIC DIATHESIS 45 0.0126
316 COMPRESSION FRACTURE 67 0.0125
317 OSTEOPENIA 188 0.0124
318 MYASTHENIA GRAVIS 100 0.0124
319 HYPERTENSION 2622 0.0124
320 RENAL FAILURE CHRONIC 95 0.0123
321 LOW TURNOVER OSTEOPATHY 49 0.0123
322 WEIGHT FLUCTUATION 127 0.0121
323 COLITIS ULCERATIVE 542 0.0121
324 KIDNEY TRANSPLANT REJECTION 58 0.0121
325 UPPER RESPIRATORY TRACT INFECTION 557 0.0120
326 TROPONIN INCREASED 91 0.0119
327 SUSPECTED OFF LABEL USE 54 0.0119
328 SPINAL COMPRESSION FRACTURE 98 0.0118
329 SPINAL CORD COMPRESSION 46 0.0118
330 HEPATOTOXICITY 263 0.0118
331 ARTHRITIS 928 0.0118
332 WRIST FRACTURE 141 0.0118
333 EOSINOPHIL COUNT INCREASED 98 0.0117
334 TIBIA FRACTURE 55 0.0117
335 RENAL TUBULAR NECROSIS 115 0.0117
336 GINGIVAL PAIN 93 0.0117
337 PROCTALGIA 75 0.0117
338 PREGNANCY 233 0.0116
339 APPENDICITIS 108 0.0116
340 ANAL FISSURE 62 0.0115
341 EATING DISORDER 246 0.0115
342 STAPHYLOCOCCAL SEPSIS 57 0.0115
343 TOXIC EPIDERMAL NECROLYSIS 175 0.0115
344 MIGRAINE 1099 0.0115
345 PRODUCTIVE COUGH 547 0.0114
346 MUSCULAR WEAKNESS 1299 0.0114
347 ARTHRITIS INFECTIVE 53 0.0114
348 BLOOD PRESSURE SYSTOLIC INCREASED 220 0.0113
349 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 46 0.0113
350 HUMERUS FRACTURE 54 0.0112
351 RESPIRATORY DISORDER 334 0.0112
352 TENDERNESS 116 0.0111
353 BODY HEIGHT DECREASED 119 0.0111
354 HYPERTRANSAMINASAEMIA 77 0.0111
355 PROTEIN URINE PRESENT 55 0.0110
356 ALOPECIA 2166 0.0110
357 ASPHYXIA 90 0.0110
358 SNEEZING 247 0.0110
359 NASOPHARYNGITIS 2017 0.0109
360 PERIPHERAL SWELLING 1669 0.0108
361 IRON DEFICIENCY ANAEMIA 100 0.0108
362 DYSPNOEA EXERTIONAL 406 0.0108
363 FLANK PAIN 101 0.0108
364 DIVERTICULUM INTESTINAL 47 0.0107
365 PNEUMOTHORAX 170 0.0107
366 VENTRICULAR FIBRILLATION 119 0.0107
367 BLOOD PRESSURE DIASTOLIC DECREASED 79 0.0107
368 LUMBAR VERTEBRAL FRACTURE 49 0.0107
369 ELECTROLYTE IMBALANCE 124 0.0107
370 NEPHROPATHY 99 0.0106
371 APPETITE DISORDER 70 0.0105
372 BLOOD BILIRUBIN INCREASED 285 0.0105
373 HYPOXIA 369 0.0105
374 DRUG TOLERANCE 53 0.0105
375 INFECTION 1515 0.0105
376 SYNOVIAL CYST 48 0.0104
377 PNEUMONIA 3365 0.0104
378 HYPOTHYROIDISM 331 0.0104
379 TRICUSPID VALVE INCOMPETENCE 82 0.0103
380 URTICARIA 1722 0.0103
381 VITAMIN D DEFICIENCY 100 0.0102
382 COLITIS 386 0.0102
383 EOSINOPHILIA 178 0.0101
384 HYPERSENSITIVITY 1885 0.0101
385 FEMORAL NECK FRACTURE 52 0.0101
386 BLOOD TEST ABNORMAL 142 0.0101
387 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 526 0.0101
388 OVERWEIGHT 54 0.0100
389 SKIN TIGHTNESS 47 0.0100
390 TUBULOINTERSTITIAL NEPHRITIS 187 0.0100
391 BLOOD UREA INCREASED 167 0.0100
392 ULCER 158 0.0099
393 SPINAL OSTEOARTHRITIS 86 0.0098
394 EMPHYSEMA 98 0.0097
395 GOUT 174 0.0097
396 CYSTITIS 306 0.0096
397 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 52 0.0095
398 WEIGHT INCREASED 2133 0.0095
399 OESOPHAGITIS 104 0.0095
400 BLOOD MAGNESIUM DECREASED 82 0.0095
401 CHEST PAIN 1748 0.0094
402 PAROSMIA 71 0.0094
403 TOOTH FRACTURE 103 0.0093
404 SQUAMOUS CELL CARCINOMA OF SKIN 56 0.0093
405 ABDOMINAL TENDERNESS 46 0.0093
406 HEPATITIS 237 0.0093
407 HAEMATOCRIT DECREASED 183 0.0092
408 CONDITION AGGRAVATED 2779 0.0091
409 HAEMORRHOIDS 178 0.0091
410 SKIN WARM 53 0.0091
411 BLOOD CREATININE INCREASED 593 0.0091
412 FAILURE TO THRIVE 47 0.0090
413 FEMUR FRACTURE 280 0.0090
414 VITAMIN D DECREASED 77 0.0090
415 PYREXIA 3108 0.0090
416 DECREASED APPETITE 2079 0.0089
417 MEDICATION ERROR 495 0.0089
418 HYPOALBUMINAEMIA 69 0.0089
419 HYDRONEPHROSIS 66 0.0088
420 HIATUS HERNIA 114 0.0088
421 ACUTE RESPIRATORY FAILURE 168 0.0087
422 HYPOKALAEMIA 403 0.0087
423 FEBRILE NEUTROPENIA 579 0.0087
424 MEMORY IMPAIRMENT 1198 0.0087
425 UPPER GASTROINTESTINAL HAEMORRHAGE 146 0.0087
426 TRANSPLANT REJECTION 69 0.0086
427 RIB FRACTURE 177 0.0086
428 MICTURITION URGENCY 98 0.0086
429 BLOOD COUNT ABNORMAL 130 0.0086
430 BODY TEMPERATURE DECREASED 84 0.0085
431 ESCHERICHIA INFECTION 70 0.0085
432 CARDIOGENIC SHOCK 122 0.0085
433 NECK PAIN 474 0.0085
434 GASTROENTERITIS 123 0.0084
435 RHINORRHOEA 540 0.0083
436 HYPONATRAEMIA 468 0.0083
437 NEUTROPHIL COUNT INCREASED 85 0.0083
438 PSYCHOTIC DISORDER 244 0.0083
439 UROSEPSIS 76 0.0082
440 APHASIA 248 0.0082
441 ANGINA PECTORIS 234 0.0082
442 ATRIAL FLUTTER 65 0.0081
443 GLOMERULAR FILTRATION RATE DECREASED 100 0.0081
444 POOR VENOUS ACCESS 84 0.0081
445 ABDOMINAL PAIN 1883 0.0081
446 CORONARY ARTERY DISEASE 244 0.0080
447 BACTERIAL INFECTION 150 0.0080
448 LUNG INFILTRATION 71 0.0080
449 VOMITING 3771 0.0080
450 HYPERKALAEMIA 279 0.0079
451 ABDOMINAL PAIN UPPER 1637 0.0079
452 GAIT DISTURBANCE 1511 0.0079
453 BREAST MASS 53 0.0079
454 SMALL INTESTINAL OBSTRUCTION 97 0.0079
455 MITRAL VALVE INCOMPETENCE 89 0.0079
456 BLOOD ALKALINE PHOSPHATASE INCREASED 195 0.0078
457 PARAESTHESIA 1232 0.0078
458 CARDIOMEGALY 96 0.0078
459 PURPURA 69 0.0078
460 LABORATORY TEST ABNORMAL 230 0.0078
461 SPINAL FRACTURE 156 0.0078
462 ASPIRATION 85 0.0078
463 PAIN IN EXTREMITY 2284 0.0077
464 PYELONEPHRITIS 67 0.0077
465 TRANSFUSION 81 0.0077
466 MUSCLE SPASMS 1417 0.0077
467 WHITE BLOOD CELL COUNT INCREASED 296 0.0077
468 HAEMATOCHEZIA 425 0.0077
469 DEVICE RELATED INFECTION 118 0.0077
470 RED BLOOD CELL COUNT DECREASED 219 0.0077
471 PRODUCT USE ISSUE 1437 0.0076
472 ABDOMINAL DISTENSION 798 0.0076
473 MYOCARDIAL ISCHAEMIA 87 0.0076
474 FLUID OVERLOAD 111 0.0076
475 ARTHRALGIA 3155 0.0076
476 ADVERSE DRUG REACTION 681 0.0076
477 HEPATIC STEATOSIS 141 0.0076
478 METASTASES TO BONE 124 0.0075
479 PULMONARY EMBOLISM 711 0.0075
480 PLEURAL EFFUSION 454 0.0075
481 PEMPHIGOID 56 0.0074
482 DYSARTHRIA 278 0.0074
483 HAEMODIALYSIS 62 0.0074
484 ANAL INCONTINENCE 66 0.0073
485 PELVIC FRACTURE 57 0.0073
486 CHOLECYSTITIS 87 0.0073
487 CROHN'S DISEASE 50 0.0073
488 WEIGHT DECREASED 2030 0.0073
489 ASCITES 213 0.0072
490 LEUKOCYTOSIS 131 0.0072
491 HAEMOGLOBIN DECREASED 743 0.0072
492 DIABETES MELLITUS INADEQUATE CONTROL 128 0.0072
493 COGNITIVE DISORDER 337 0.0072
494 ADVERSE EVENT 664 0.0072
495 CATARACT 428 0.0072
496 PROCEDURAL PAIN 199 0.0072
497 ASTHENIA 2695 0.0072
498 MULTIPLE ALLERGIES 56 0.0071
499 INTERVERTEBRAL DISC DEGENERATION 66 0.0071
500 ACUTE KIDNEY INJURY 1089 0.0071
501 ANAEMIA 1355 0.0071
502 SEASONAL ALLERGY 100 0.0071
503 MENTAL STATUS CHANGES 196 0.0071
504 DYSPNOEA 3991 0.0070
505 LOW BIRTH WEIGHT BABY 56 0.0070
506 ATRIAL FIBRILLATION 686 0.0070
507 COMA 334 0.0070
508 RESPIRATORY RATE INCREASED 62 0.0070
509 JOINT EFFUSION 48 0.0070
510 OSTEOMYELITIS 126 0.0070
511 CYTOKINE RELEASE SYNDROME 139 0.0069
512 BACTERAEMIA 82 0.0069
513 BRONCHITIS 511 0.0069
514 PAIN 4186 0.0068
515 MALAISE 2988 0.0068
516 FALL 2253 0.0068
517 LYMPHOCYTE COUNT DECREASED 119 0.0067
518 CONSTIPATION 1466 0.0067
519 BLOOD PRESSURE FLUCTUATION 161 0.0067
520 URINE OUTPUT DECREASED 58 0.0066
521 ELECTROCARDIOGRAM ABNORMAL 52 0.0066
522 ORAL PAIN 148 0.0066
523 HAEMATURIA 226 0.0066
524 CELLULITIS 329 0.0065
525 TRANSAMINASES INCREASED 145 0.0065
526 DUODENAL ULCER 46 0.0065
527 LYMPHOEDEMA 45 0.0065
528 LARGE INTESTINE POLYP 45 0.0065
529 RENAL FAILURE ACUTE 275 0.0065
530 BONE DISORDER 118 0.0065
531 GASTRIC ULCER 123 0.0065
532 AUTOIMMUNE HEPATITIS 45 0.0065
533 BLOOD POTASSIUM DECREASED 194 0.0064
534 ILEUS 80 0.0064
535 HIP FRACTURE 207 0.0064
536 NICOTINE DEPENDENCE 50 0.0064
537 FATIGUE 5001 0.0064
538 PETECHIAE 67 0.0064
539 ECCHYMOSIS 44 0.0064
540 ACIDOSIS 49 0.0064
541 RASH 2789 0.0064
542 GROIN PAIN 56 0.0064
543 DEPRESSION 1449 0.0064
544 SEPTIC SHOCK 276 0.0063
545 FOOT FRACTURE 120 0.0063
546 PRODUCT USE IN UNAPPROVED INDICATION 1566 0.0063
547 LYMPHOPENIA 89 0.0063
548 BALANCE DISORDER 543 0.0063
549 MOUTH ULCERATION 132 0.0063
550 DECUBITUS ULCER 51 0.0063
551 BONE PAIN 366 0.0062
552 THROMBOSIS 502 0.0062
553 ARTHROPOD BITE 46 0.0062
554 SEPSIS 691 0.0062
555 TOOTH ABSCESS 63 0.0062
556 CHEST DISCOMFORT 632 0.0062
557 PNEUMONITIS 168 0.0062
558 SEDATION 161 0.0061
559 HEART RATE DECREASED 215 0.0061
560 ANXIETY 1737 0.0061
561 ADRENAL INSUFFICIENCY 74 0.0061
562 MALNUTRITION 68 0.0061
563 MULTIPLE ORGAN DYSFUNCTION SYNDROME 172 0.0061
564 PSEUDOMONAS INFECTION 52 0.0061
565 HAEMATOMA 156 0.0060
566 LEUKOPENIA 301 0.0060
567 NEURALGIA 146 0.0060
568 LIPASE INCREASED 46 0.0060
569 BONE DENSITY DECREASED 188 0.0060
570 DRUG LEVEL DECREASED 61 0.0060
571 CHRONIC KIDNEY DISEASE 455 0.0060
572 DIARRHOEA 3853 0.0060
573 INTERNATIONAL NORMALISED RATIO INCREASED 170 0.0060
574 BLOOD SODIUM DECREASED 112 0.0059
575 RESTLESS LEGS SYNDROME 108 0.0059
576 TACHYCARDIA 525 0.0059
577 BASAL CELL CARCINOMA 92 0.0059
578 BOWEL MOVEMENT IRREGULARITY 45 0.0059
579 BLOOD POTASSIUM INCREASED 95 0.0058
580 PERITONITIS 121 0.0058
581 PRESYNCOPE 142 0.0058
582 DEPRESSED LEVEL OF CONSCIOUSNESS 231 0.0058
583 MELAENA 128 0.0058
584 FLUID RETENTION 294 0.0058
585 IMPAIRED QUALITY OF LIFE 83 0.0058
586 ACUTE MYOCARDIAL INFARCTION 170 0.0058
587 PULMONARY HYPERTENSION 120 0.0058
588 SKIN LESION 158 0.0058
589 COVID-19 PNEUMONIA 68 0.0058
590 COUGH 1613 0.0057
591 PERITONITIS BACTERIAL 58 0.0057
592 THERAPEUTIC RESPONSE DECREASED 348 0.0057
593 MULTI-ORGAN FAILURE 99 0.0057
594 NASAL CONGESTION 336 0.0057
595 THROMBOCYTOPENIA 638 0.0057
596 INSOMNIA 1518 0.0057
597 GASTRITIS 149 0.0057
598 DYSPHAGIA 537 0.0057
599 GENERALISED OEDEMA 70 0.0056
600 OROPHARYNGEAL DISCOMFORT 51 0.0056
601 DYSPHONIA 330 0.0056
602 SINUS TACHYCARDIA 80 0.0056
603 BLOOD PRESSURE INCREASED 860 0.0056
604 UPPER LIMB FRACTURE 112 0.0056
605 BRONCHOSPASM 80 0.0056
606 PANCYTOPENIA 313 0.0056
607 INTERVERTEBRAL DISC PROTRUSION 122 0.0056
608 DRUG INTERACTION 885 0.0056
609 NAUSEA 4415 0.0056
610 LIGAMENT SPRAIN 55 0.0056
611 NEPHROLITHIASIS 255 0.0056
612 MUSCULOSKELETAL CHEST PAIN 86 0.0056
613 DEEP VEIN THROMBOSIS 361 0.0055
614 SKIN ULCER 143 0.0055
615 VISUAL IMPAIRMENT 685 0.0055
616 URINARY TRACT INFECTION 939 0.0055
617 ECONOMIC PROBLEM 83 0.0055
618 OSTEONECROSIS OF JAW 135 0.0054
619 BODY TEMPERATURE INCREASED 111 0.0054
620 HYPOPHAGIA 139 0.0054
621 RENAL IMPAIRMENT 456 0.0054
622 TENDON RUPTURE 67 0.0054
623 SKIN DISORDER 181 0.0054
624 FISTULA 61 0.0054
625 LUNG INFECTION 84 0.0054
626 SLEEP APNOEA SYNDROME 103 0.0054
627 PULMONARY OEDEMA 241 0.0054
628 MUSCLE TWITCHING 124 0.0054
629 TOOTH DISORDER 118 0.0053
630 PULMONARY MASS 79 0.0053
631 IMMUNODEFICIENCY 79 0.0053
632 ANKLE FRACTURE 82 0.0053
633 PAIN IN JAW 150 0.0053
634 DIZZINESS 2637 0.0053
635 PANCREATITIS 279 0.0053
636 HEADACHE 3308 0.0053
637 HOT FLUSH 396 0.0052
638 LIMB INJURY 142 0.0052
639 ATAXIA 62 0.0052
640 WHITE BLOOD CELL COUNT DECREASED 566 0.0052
641 MYOCLONUS 62 0.0052
642 PNEUMOCYSTIS JIROVECII PNEUMONIA 52 0.0052
643 SPINAL DISORDER 49 0.0052
644 ENCEPHALOPATHY 127 0.0052
645 PALPITATIONS 605 0.0052
646 FULL BLOOD COUNT DECREASED 104 0.0052
647 ASPARTATE AMINOTRANSFERASE INCREASED 274 0.0052
648 RENAL FAILURE 683 0.0051
649 INFLUENZA 572 0.0051
650 MUSCULOSKELETAL DISCOMFORT 88 0.0051
651 CARDIAC FAILURE CONGESTIVE 410 0.0051
652 PERICARDIAL EFFUSION 118 0.0051
653 IMMUNOSUPPRESSION 45 0.0051
654 DEHYDRATION 680 0.0051
655 EJECTION FRACTION DECREASED 79 0.0051
656 TOOTHACHE 92 0.0051
657 RHABDOMYOLYSIS 211 0.0051
658 BLOOD LACTATE DEHYDROGENASE INCREASED 80 0.0050
659 FEELING HOT 309 0.0050
660 OFF LABEL USE 4397 0.0050
661 PSORIASIS 655 0.0050
662 GAMMA-GLUTAMYLTRANSFERASE INCREASED 111 0.0050
663 METASTASES TO LIVER 88 0.0050
664 TOOTH INFECTION 66 0.0050
665 BACK PAIN 1163 0.0050
666 PLATELET COUNT INCREASED 65 0.0050
667 PRURITUS 1915 0.0050
668 DYSSTASIA 145 0.0050
669 SUBDURAL HAEMATOMA 71 0.0050
670 UNDERDOSE 362 0.0050
671 DRUG LEVEL INCREASED 82 0.0049
672 OXYGEN SATURATION DECREASED 278 0.0049
673 RASH PRURITIC 268 0.0049
674 RASH MACULO-PAPULAR 110 0.0049
675 NOCTURIA 60 0.0049
676 BREAST CANCER METASTATIC 53 0.0049
677 HYPOTENSION 988 0.0049
678 RESPIRATORY FAILURE 359 0.0049
679 JOINT INJURY 105 0.0049
680 SUPRAVENTRICULAR TACHYCARDIA 47 0.0049
681 CLOSTRIDIUM DIFFICILE INFECTION 107 0.0049
682 MUSCLE ATROPHY 62 0.0049
683 BLOOD IRON DECREASED 58 0.0049
684 CARPAL TUNNEL SYNDROME 68 0.0049
685 STAPHYLOCOCCAL INFECTION 160 0.0048
686 RASH ERYTHEMATOUS 231 0.0048
687 RESPIRATORY DISTRESS 133 0.0048
688 DIARRHOEA HAEMORRHAGIC 45 0.0048
689 OSTEONECROSIS 158 0.0048
690 VENTRICULAR TACHYCARDIA 79 0.0048
691 METABOLIC ACIDOSIS 152 0.0047
692 HYPERGLYCAEMIA 173 0.0047
693 SWOLLEN TONGUE 148 0.0047
694 BLADDER DISORDER 47 0.0047
695 PREMATURE DELIVERY 75 0.0047
696 CARDIO-RESPIRATORY ARREST 196 0.0047
697 PROTEINURIA 89 0.0047
698 NEUROTOXICITY 82 0.0047
699 GASTROINTESTINAL HAEMORRHAGE 388 0.0046
700 SKIN INFECTION 52 0.0046
701 CYTOMEGALOVIRUS INFECTION 77 0.0046
702 NEPHROPATHY TOXIC 52 0.0046
703 HYPERTHYROIDISM 67 0.0046
704 PULMONARY CONGESTION 61 0.0046
705 ECZEMA 242 0.0046
706 TREATMENT NONCOMPLIANCE 253 0.0046
707 SKIN EXFOLIATION 390 0.0046
708 INJECTION SITE REACTION 318 0.0046
709 HEART RATE IRREGULAR 104 0.0046
710 SKIN LACERATION 50 0.0046
711 INFLUENZA LIKE ILLNESS 378 0.0046
712 HEPATOMEGALY 45 0.0046
713 PLATELET COUNT DECREASED 484 0.0045
714 HYPERBILIRUBINAEMIA 47 0.0045
715 TRANSIENT ISCHAEMIC ATTACK 153 0.0045
716 PROSTATIC SPECIFIC ANTIGEN INCREASED 62 0.0045
717 SOMNOLENCE 906 0.0045
718 VIRAL INFECTION 149 0.0045
719 UNRESPONSIVE TO STIMULI 115 0.0045
720 RENAL INJURY 132 0.0044
721 COAGULOPATHY 74 0.0044
722 ALANINE AMINOTRANSFERASE INCREASED 272 0.0044
723 DENTAL CARIES 49 0.0044
724 INFUSION SITE PAIN 57 0.0044
725 MOVEMENT DISORDER 142 0.0044
726 URINARY INCONTINENCE 131 0.0044
727 PLASMA CELL MYELOMA 172 0.0044
728 EAR DISCOMFORT 45 0.0044
729 MUSCLE TIGHTNESS 71 0.0044
730 NEUROPATHY PERIPHERAL 415 0.0044
731 ROTATOR CUFF SYNDROME 56 0.0044
732 INCONTINENCE 46 0.0043
733 INTESTINAL OBSTRUCTION 164 0.0043
734 DIABETES MELLITUS 330 0.0043
735 IMMUNE SYSTEM DISORDER 57 0.0043
736 HYPERTENSIVE CRISIS 48 0.0043
737 LOCALISED INFECTION 104 0.0043
738 ANHEDONIA 113 0.0043
739 DIALYSIS 61 0.0043
740 MASS 60 0.0043
741 BLOOD URINE PRESENT 81 0.0043
742 DEMENTIA 119 0.0043
743 CHILLS 498 0.0042
744 HYPOGLYCAEMIA 206 0.0042
745 POLLAKIURIA 177 0.0042
746 ELECTROCARDIOGRAM QT PROLONGED 152 0.0042
747 PERIPHERAL COLDNESS 58 0.0042
748 CARDIAC ARREST 348 0.0042
749 DYSURIA 155 0.0042
750 BRADYCARDIA 223 0.0042
751 PHOTOPHOBIA 79 0.0042
752 NEUTROPHIL COUNT DECREASED 171 0.0042
753 IMPAIRED WORK ABILITY 89 0.0042
754 INTERSTITIAL LUNG DISEASE 201 0.0041
755 DIVERTICULITIS 115 0.0041
756 MYALGIA 705 0.0041
757 HAEMATEMESIS 105 0.0041
758 CARDIOMYOPATHY 61 0.0041
759 HEAD INJURY 130 0.0041
760 NEUTROPENIA 555 0.0041
761 RENAL DISORDER 190 0.0041
762 KIDNEY INFECTION 80 0.0041
763 SPINAL PAIN 47 0.0040
764 PHOTOSENSITIVITY REACTION 66 0.0040
765 CEREBROVASCULAR ACCIDENT 676 0.0040
766 LIVER FUNCTION TEST ABNORMAL 116 0.0040
767 LETHARGY 229 0.0040
768 LIMB DISCOMFORT 123 0.0040
769 FRACTURE 75 0.0040
770 CYST 49 0.0039
771 DISSEMINATED INTRAVASCULAR COAGULATION 55 0.0039
772 TACHYPNOEA 53 0.0039
773 BLOOD PRESSURE DECREASED 257 0.0039
774 SYNCOPE 386 0.0039
775 MUSCLE RIGIDITY 46 0.0038
776 SPLENOMEGALY 45 0.0038
777 DEPRESSED MOOD 203 0.0038
778 VERTIGO 233 0.0038
779 EPISTAXIS 284 0.0038
780 HYPOKINESIA 55 0.0038
781 MUCOSAL INFLAMMATION 99 0.0038
782 CARDIAC DISORDER 352 0.0038
783 HALLUCINATION, VISUAL 79 0.0037
784 DISORIENTATION 148 0.0037
785 ERUCTATION 72 0.0037
786 URINARY RETENTION 124 0.0037
787 PHARYNGITIS 46 0.0037
788 ABSCESS 59 0.0037
789 ACTIVITIES OF DAILY LIVING IMPAIRED 73 0.0037
790 LYMPHADENOPATHY 130 0.0037
791 IMPAIRED GASTRIC EMPTYING 50 0.0037
792 LIP SWELLING 122 0.0037
793 RASH PAPULAR 82 0.0037
794 ISCHAEMIC STROKE 65 0.0036
795 CARDIAC FAILURE 292 0.0036
796 TOOTH EXTRACTION 45 0.0036
797 ERYTHEMA 743 0.0036
798 PANCREATITIS ACUTE 81 0.0036
799 LUNG NEOPLASM MALIGNANT 148 0.0036
800 PREMATURE BABY 108 0.0036
801 HYPOAESTHESIA ORAL 54 0.0036
802 DERMATITIS 75 0.0036
803 BLOOD CREATINE PHOSPHOKINASE INCREASED 103 0.0036
804 CEREBRAL HAEMORRHAGE 128 0.0036
805 LOSS OF CONSCIOUSNESS 456 0.0036
806 TINNITUS 163 0.0035
807 ABASIA 87 0.0035
808 HEART RATE INCREASED 346 0.0035
809 FEELING COLD 97 0.0035
810 MIDDLE INSOMNIA 65 0.0035
811 GALLBLADDER DISORDER 62 0.0035
812 ACCIDENTAL OVERDOSE 126 0.0034
813 MALIGNANT MELANOMA 46 0.0034
814 BLOOD PRESSURE ABNORMAL 68 0.0034
815 PALLOR 93 0.0034
816 FAECES DISCOLOURED 74 0.0034
817 BONE LOSS 51 0.0034
818 DRUG ERUPTION 60 0.0034
819 POST PROCEDURAL COMPLICATION 65 0.0034
820 GENERALISED TONIC-CLONIC SEIZURE 56 0.0034
821 HYPERSOMNIA 97 0.0034
822 GASTROENTERITIS VIRAL 61 0.0034
823 INJECTION SITE HAEMATOMA 49 0.0034
824 FLATULENCE 191 0.0034
825 CONVULSION 192 0.0034
826 FEEDING DISORDER 68 0.0033
827 CONJUNCTIVITIS 62 0.0033
828 OROPHARYNGEAL PAIN 309 0.0033
829 ORAL HERPES 65 0.0033
830 GLAUCOMA 64 0.0033
831 TREMOR 548 0.0033
832 RETCHING 70 0.0033
833 HAEMORRHAGE INTRACRANIAL 49 0.0033
834 HERPES ZOSTER 188 0.0033
835 RASH MACULAR 114 0.0033
836 CANDIDA INFECTION 55 0.0033
837 BRAIN FOG 51 0.0033
838 NEOPLASM PROGRESSION 113 0.0032
839 PRODUCT QUALITY ISSUE 441 0.0032
840 CHOKING 63 0.0032
841 HOSPITALISATION 495 0.0032
842 FUNGAL INFECTION 107 0.0032
843 GASTRIC DISORDER 110 0.0032
844 FEELING JITTERY 61 0.0032
845 SKIN DISCOLOURATION 147 0.0032
846 CARDIOVASCULAR DISORDER 81 0.0032
847 CYANOSIS 50 0.0032
848 ABDOMINAL PAIN LOWER 80 0.0032
849 FEAR 85 0.0032
850 SCAR 54 0.0032
851 DYSGEUSIA 233 0.0031
852 MENTAL IMPAIRMENT 76 0.0031
853 SEROTONIN SYNDROME 60 0.0031
854 THINKING ABNORMAL 58 0.0031
855 CIRCULATORY COLLAPSE 53 0.0031
856 MULTIPLE FRACTURES 51 0.0031
857 COVID-19 543 0.0031
858 INCREASED APPETITE 59 0.0031
859 INTENTIONAL DOSE OMISSION 88 0.0031
860 HALLUCINATION 232 0.0031
861 SWELLING FACE 200 0.0031
862 POOR QUALITY SLEEP 66 0.0031
863 THIRST 54 0.0030
864 JAUNDICE 81 0.0030
865 HERNIA 58 0.0030
866 MALIGNANT NEOPLASM PROGRESSION 306 0.0030
867 NERVOUSNESS 156 0.0030
868 TENDONITIS 46 0.0030
869 DRUG INEFFECTIVE 3914 0.0030
870 HEPATIC FAILURE 89 0.0029
871 THROAT IRRITATION 132 0.0029
872 THYROID DISORDER 45 0.0029
873 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 520 0.0029
874 HEAD DISCOMFORT 51 0.0029
875 MENTAL DISORDER 125 0.0029
876 BONE MARROW FAILURE 58 0.0029
877 SKIN CANCER 61 0.0028
878 HYPERHIDROSIS 364 0.0028
879 SPEECH DISORDER 147 0.0028
880 CHROMATURIA 63 0.0028
881 HYPOACUSIS 120 0.0028
882 FACE OEDEMA 47 0.0028
883 CEREBRAL INFARCTION 68 0.0028
884 BLOOD TRIGLYCERIDES INCREASED 49 0.0028
885 ARRHYTHMIA 131 0.0028
886 EYE PAIN 156 0.0028
887 FOETAL EXPOSURE DURING PREGNANCY 224 0.0028
888 LACRIMATION INCREASED 83 0.0027
889 HAEMORRHAGE 286 0.0027
890 DIPLOPIA 71 0.0027
891 DISEASE PROGRESSION 322 0.0027
892 NIGHTMARE 94 0.0027
893 PRURITUS GENERALISED 58 0.0027
894 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
895 AGEUSIA 66 0.0026
896 LACTIC ACIDOSIS 85 0.0026
897 RESTLESSNESS 95 0.0026
898 AGITATION 190 0.0026
899 LOCAL SWELLING 45 0.0026
900 DRY EYE 128 0.0026
901 DEAFNESS 67 0.0026
902 FEELING ABNORMAL 610 0.0025
903 SEIZURE 293 0.0025
904 SHOCK 58 0.0025
905 OCULAR HYPERAEMIA 119 0.0025
906 EYE SWELLING 93 0.0025
907 EYE DISORDER 81 0.0025
908 CRYING 89 0.0024
909 UNEVALUABLE EVENT 185 0.0024
910 AGRANULOCYTOSIS 45 0.0024
911 INTENTIONAL PRODUCT MISUSE 211 0.0024
912 ANAPHYLACTIC REACTION 133 0.0024
913 DISEASE RECURRENCE 114 0.0024
914 CHOLESTASIS 46 0.0024
915 DYSKINESIA 96 0.0024
916 ABNORMAL BEHAVIOUR 93 0.0023
917 TOOTH LOSS 48 0.0023
918 FLUSHING 235 0.0023
919 EMOTIONAL DISORDER 71 0.0023
920 ILLNESS 236 0.0023
921 DRUG ADMINISTRATION ERROR 70 0.0023
922 RASH GENERALISED 59 0.0023
923 BURNING SENSATION 159 0.0023
924 INTENTIONAL DRUG MISUSE 47 0.0022
925 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 52 0.0022
926 OVERDOSE 476 0.0022
927 TOXICITY TO VARIOUS AGENTS 369 0.0022
928 THROAT TIGHTNESS 59 0.0022
929 ANAPHYLACTIC SHOCK 56 0.0022
930 HEPATIC FUNCTION ABNORMAL 79 0.0021
931 PRODUCT AVAILABILITY ISSUE 48 0.0021
932 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
933 VISION BLURRED 284 0.0021
934 RESPIRATORY ARREST 57 0.0021
935 GLYCOSYLATED HAEMOGLOBIN INCREASED 52 0.0021
936 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 53 0.0021
937 DEATH 1713 0.0020
938 MYOCARDIAL INFARCTION 342 0.0020
939 TARDIVE DYSKINESIA 55 0.0019
940 DRY SKIN 258 0.0019
941 DIABETIC KETOACIDOSIS 46 0.0019
942 NEOPLASM MALIGNANT 126 0.0019
943 EMOTIONAL DISTRESS 228 0.0019
944 SURGERY 109 0.0019
945 THERAPEUTIC RESPONSE UNEXPECTED 83 0.0018
946 ANGER 60 0.0018
947 NERVOUS SYSTEM DISORDER 55 0.0018
948 EYE PRURITUS 59 0.0018
949 THERAPY INTERRUPTED 123 0.0017
950 DRUG DOSE OMISSION 279 0.0017
951 VISUAL ACUITY REDUCED 56 0.0017
952 ANGIOEDEMA 72 0.0016
953 DISTURBANCE IN ATTENTION 87 0.0016
954 MULTIPLE SCLEROSIS 77 0.0016
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 88 0.0016
956 THERAPEUTIC RESPONSE SHORTENED 53 0.0016
957 BLINDNESS 65 0.0016
958 BLOOD GLUCOSE DECREASED 76 0.0016
959 PRODUCT DOSE OMISSION ISSUE 459 0.0016
960 PRODUCT DOSE OMISSION 100 0.0015
961 BLOOD GLUCOSE INCREASED 286 0.0015
962 WRONG TECHNIQUE IN DRUG USAGE PROCESS 55 0.0015
963 PANIC ATTACK 54 0.0015
964 MOOD SWINGS 47 0.0015
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 104 0.0015
966 EYE IRRITATION 84 0.0015
967 MULTIPLE SCLEROSIS RELAPSE 100 0.0015
968 DRUG DEPENDENCE 233 0.0014
969 ACNE 106 0.0014
970 SUICIDAL IDEATION 127 0.0014
971 IRRITABILITY 82 0.0014
972 INCORRECT DOSE ADMINISTERED 288 0.0013
973 INJECTION SITE ERYTHEMA 150 0.0012
974 PROSTATE CANCER 97 0.0012
975 SUICIDE ATTEMPT 73 0.0012
976 AGGRESSION 60 0.0012
977 DRUG ABUSE 97 0.0012
978 SKIN IRRITATION 53 0.0012
979 NO ADVERSE EVENT 209 0.0012
980 THERAPY CESSATION 58 0.0011
981 BREAST CANCER 104 0.0011
982 INJECTION SITE HAEMORRHAGE 86 0.0011
983 VAGINAL HAEMORRHAGE 45 0.0010
984 DEPENDENCE 53 0.0010
985 INJECTION SITE PRURITUS 64 0.0010
986 SKIN BURNING SENSATION 67 0.0009
987 INJECTION SITE PAIN 285 0.0009
988 INJECTION SITE BRUISING 72 0.0009
989 INJECTION SITE SWELLING 66 0.0009
990 DEVICE ISSUE 75 0.0008
991 INTENTIONAL OVERDOSE 46 0.0007
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 128 0.0006
993 DRUG WITHDRAWAL SYNDROME 47 0.0005